Literature DB >> 14639148

Relative analgesic potencies of levobupivacaine and ropivacaine for epidural analgesia in labor.

Linda S Polley1, Malachy O Columb, Norah N Naughton, Deborah S Wagner, Cosmas J M van de Ven, Kathryn H Goralski.   

Abstract

BACKGROUND: The minimum local analgesic concentration has been defined as the median effective local analgesic concentration (EC50) in a 20-ml volume for epidural analgesia in the first stage of labor. The aim of this study was to assess the relative analgesic potencies of epidural levobupivacaine and ropivacaine by determination of their respective minimum local analgesic concentrations.
METHODS: Parturients at 7 cm of cervical dilation or less who requested epidural analgesia were allocated to one of two groups in this double-blind, randomized, prospective study. After lumbar epidural catheter placement, 20 ml of the test solution was given: levobupivacaine (n = 35) or ropivacaine (n = 35). The concentration of local anesthetic was determined by the response of the previous patient in that group to a higher or lower concentration using up-down sequential allocation. Analgesic efficacy was assessed using 100-mm visual analog pain scale scores, with 10 mm or less within 30 min defined as effective. An effective result directed a 0.01% wt/vol decrement for the next patient. An ineffective result directed a 0.01% wt/vol increment.
RESULTS: Of 105 women enrolled, 35 were excluded, leaving 70 for analysis. The minimum local analgesic concentration of levobupivacaine was 0.087% wt/vol (95% CI, 0.081-0.094%), and the minimum local analgesic concentration of ropivacaine was 0.089% wt/vol (95% CI, 0.075-0.103%). Levobupivacaine and ropivacaine were of similar potency with a ropivacaine:levobupivacaine potency ratio of 0.98 (95% CI, 0.80-1.20). No difference in motor effects was observed.
CONCLUSIONS: This study demonstrated that levobupivacaine and ropivacaine are of similar potency for epidural analgesia in the first stage of labor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14639148     DOI: 10.1097/00000542-200312000-00017

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  14 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

Review 3.  Levobupivacaine: a review of its use in regional anaesthesia and pain management.

Authors:  Mark Sanford; Gillian M Keating
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

Review 4.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Median Effective Concentration of Ropivacaine for Femoral Nerve Block Maintaining Motor Function During Knee Arthroscopy in Two Age Groups.

Authors:  Yan-Lei Tai; Li Peng; Ying Wang; Zi-Jun Zhao; Ya-Nan Li; Chun-Ping Yin; Zhi-Yong Hou; De-Cheng Shao; Ya-Hui Zhang; Qiu-Jun Wang
Journal:  J Pain Res       Date:  2022-06-07       Impact factor: 2.832

Review 6.  [Levobupivacaine in obstetric analgesia and anaesthesia. Where is its place?].

Authors:  D H Bremerich; B Zwissler
Journal:  Anaesthesist       Date:  2004-07       Impact factor: 1.041

Review 7.  Clinical Pharmacokinetics and Pharmacodynamics of Levobupivacaine.

Authors:  Chantal A A Heppolette; Derek Brunnen; Sohail Bampoe; Peter M Odor
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

8.  Patient-controlled epidural analgesia after Caesarean section: levobupivacaine 0.15% versus ropivacaine 0.15% alone or combined with fentanyl 2 µg/ml: a comparative study.

Authors:  Paraskevi Matsota; Chrysanthi Batistaki; Stylliani Apostolaki; Georgia Kostopanagiotou
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

9.  Comparison of 0.5% Ropivacaine and 0.5% Levobupivacaine for Sciatic Nerve Block Using Labat Approach in Foot and Ankle Surgery.

Authors:  Khushboo Malav; Geeta Singariya; Sadik Mohammed; Manoj Kamal; Pushpender Sangwan; Bharat Paliwal
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-11-27

10.  Update on local anesthetics: focus on levobupivacaine.

Authors:  Crina L Burlacu; Donal J Buggy
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.